Amplyx Pharmaceuticals' Series B Round

Amplyx Pharmaceuticals raised a round of funding on November 11, 2015.

Amplyx Pharmaceuticals is a pre-clinical stage small molecule drug development company with a portfolio of internally discovered candidates with improved the therapeutic properties. Amplyx's platform …

Articles about Amplyx Pharmaceuticals' Series B Round: